Genfit S.A. (EPA:GNFT)
 3.550
 -0.068 (-1.88%)
  Nov 3, 2025, 5:35 PM CET
Genfit Revenue
Genfit had revenue of 35.54M EUR in the half year ending June 30, 2025, with 135.16% growth. This brings the company's revenue in the last twelve months to 45.13M, down -43.93% year-over-year. In the year 2024, Genfit had annual revenue of 70.69M with 105.01% growth.
Revenue (ttm) 
 45.13M
Revenue Growth 
 -43.93%
P/S Ratio 
 3.92
Revenue / Employee 
 240.03K
Employees 
 180
Market Cap 
176.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 70.69M | 36.21M | 105.01% | 
| Dec 31, 2023 | 34.48M | 8.24M | 31.38% | 
| Dec 31, 2022 | 26.25M | -59.11M | -69.25% | 
| Dec 31, 2021 | 85.36M | 76.67M | 883.14% | 
| Dec 31, 2020 | 8.68M | -30.29M | -77.72% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Sanofi | 45.93B | 
| EssilorLuxottica Société anonyme | 27.24B | 
| Eurofins Scientific SE | 7.14B | 
| emeis Société anonyme | 5.77B | 
| Clariane SE | 5.31B | 
| bioMérieux | 4.12B | 
| Ipsen | 3.76B | 
| Sartorius Stedim Biotech | 2.95B | 
Genfit News
- 4 days ago - Genfit (GNFT) Plans to Voluntarily Delist from Nasdaq - GuruFocus
 - 4 days ago - GENFIT to delist American depositary shares from Nasdaq - Seeking Alpha
 - 4 days ago - GENFIT announces intention to voluntarily delist American Depositary Shares from The Nasdaq Global Select Market - GlobeNewsWire
 - 6 days ago - GENFIT Announces Advances Across its ACLF Pipeline at AASLD The Liver Meeting® 2025 - GlobeNewsWire
 - 25 days ago - Viking Therapeutics, Genfit, Sagimet jump as Novo to buy Akero - Seeking Alpha
 - 5 weeks ago - Genfit (GNFT): HC Wainwright & Co. Lowers Price Target To $7.00 | GNFT Stock News - GuruFocus
 - 6 weeks ago - Genfit (GNFTF) Reports 41.7% Revenue Decline in First Half of 2025 - GuruFocus
 - 6 weeks ago - Genfit S.A. GAAP EPS of -€0.20, revenue of €35.67M - Seeking Alpha